Soft Tissue Sarcoma Market Set for Significant Growth at a CAGR of 7.9% During the Forecast Period (2026-2036), Driven by Novel Therapies and Expanding Treatment Landscape | DelveInsight

Summary

Market research report projects soft tissue sarcoma market will grow at 7.9% CAGR through 2036, driven by improved disease recognition and novel therapeutic approaches including TBI-1301 and INT230-6. This is a routine market analysis announcement without clinical or regulatory catalysts.